Blue Belt Technologies received 510(k) clearance from the U.S. Food and Drug Administration for its STRIDE Unicondylar Knee implant. The STRIDE implant will be marketed with the company's NavioPFS system. The knee system is designed to treat medial and lateral compartment osteoarthritis.
More Articles on Devices:
TranS1 Renamed Baxano Surgical, Relocates Headquarters to Raleigh
SI-BONE Releases Data on 5,319 Patients Treated With iFuse Implant System
6 Device Company Acquisitions & Partnerships
More Articles on Devices:
TranS1 Renamed Baxano Surgical, Relocates Headquarters to Raleigh
SI-BONE Releases Data on 5,319 Patients Treated With iFuse Implant System
6 Device Company Acquisitions & Partnerships